Revolution Medicines, Inc. <RVMD.O>: RBC Raises Target Price to $251 From $203
RVMD•Related News
China's drug regulator accepts Novo Nordisk's application for oral Wegovy
LLY•
Williams-Sonoma Inc <WSM.N>: JP Morgan raises target price to $255 from $200
WSM•
Salesforce, Inc. <CRM.N>: RBC raises target price to $250 from $210
CRM•
Veeva Systems Inc. <VEEV.N>: Piper Sandler raises target price to $320 from $295
VEEV•
The J. M. Smucker Company: Jefferies Raises Target Price to $152 From $140
SJM•